Inflammatory Bowel Diseases
"Inflammatory Bowel Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.
| Descriptor ID |
D015212
|
| MeSH Number(s) |
C06.405.205.731 C06.405.469.432
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Inflammatory Bowel Diseases".
Below are MeSH descriptors whose meaning is more specific than "Inflammatory Bowel Diseases".
This graph shows the total number of publications written about "Inflammatory Bowel Diseases" by people in this website by year, and whether "Inflammatory Bowel Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 0 | 2 |
| 1995 | 2 | 0 | 2 |
| 1998 | 7 | 0 | 7 |
| 1999 | 3 | 0 | 3 |
| 2000 | 4 | 0 | 4 |
| 2001 | 3 | 0 | 3 |
| 2002 | 10 | 0 | 10 |
| 2003 | 7 | 1 | 8 |
| 2004 | 3 | 1 | 4 |
| 2005 | 5 | 5 | 10 |
| 2006 | 14 | 3 | 17 |
| 2007 | 9 | 1 | 10 |
| 2008 | 10 | 2 | 12 |
| 2009 | 9 | 2 | 11 |
| 2010 | 7 | 2 | 9 |
| 2011 | 6 | 1 | 7 |
| 2012 | 5 | 3 | 8 |
| 2013 | 12 | 3 | 15 |
| 2014 | 14 | 1 | 15 |
| 2015 | 22 | 2 | 24 |
| 2016 | 14 | 6 | 20 |
| 2017 | 14 | 5 | 19 |
| 2018 | 16 | 3 | 19 |
| 2019 | 23 | 5 | 28 |
| 2020 | 25 | 3 | 28 |
| 2021 | 31 | 3 | 34 |
| 2022 | 33 | 0 | 33 |
| 2023 | 23 | 1 | 24 |
| 2024 | 12 | 11 | 23 |
To return to the timeline,
click here.
Below are the most recent publications written about "Inflammatory Bowel Diseases" by people in Profiles.
-
The Disease Severity Index for Inflammatory Bowel Disease Is a Valid Instrument that Predicts Complicated Disease. Inflamm Bowel Dis. 2024 Nov 04; 30(11):2064-2075.
-
Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease. Inflamm Bowel Dis. 2024 Nov 04; 30(11):2057-2063.
-
Risk of Common Neurological Disorders in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2024 Nov 04; 30(11):2195-2204.
-
Management of Colorectal Neoplasia in IBD Patients: Current Practice and Future Perspectives. J Crohns Colitis. 2024 Oct 15; 18(10):1726-1735.
-
Real-World Persistence of Successive Biologics in Patients With Inflammatory Bowel Disease: Findings From ROTARY. Inflamm Bowel Dis. 2024 Oct 03; 30(10):1776-1787.
-
Impact of a health-system specialty pharmacy on time to upadacitinib initiation. Am J Health Syst Pharm. 2024 Sep 23; 81(19):e594-e600.
-
Evaluation of adverse clinical outcomes in patients with inflammatory bowel disease receiving different sequences of first- and second-line biologic treatments: findings from ROTARY. BMC Gastroenterol. 2024 Sep 17; 24(1):314.
-
Clinicopathologic and Molecular Characterization of Inflammatory Bowel Disease-Associated Neuroendocrine Carcinomas and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms. Mod Pathol. 2024 Oct; 37(10):100566.
-
Dysplasia Detected in Patients With Serrated Epithelial Change Is Frequently Associated With an Invisible or Flat Endoscopic Appearance, Nonconventional Dysplastic Features, and Advanced Neoplasia. Am J Surg Pathol. 2024 Oct 01; 48(10):1326-1334.
-
Development of Luminescent Biosensors for Calprotectin. ACS Chem Biol. 2024 Jun 21; 19(6):1250-1259.